QED International Associates Announces Changes to the HealthShares(TM) Composite, and the HealthShares(TM) Diagnostics Indexes

Wednesday, November 7, 2007 General News J E 4
NEW YORK, Nov. 6 QED International Associates Inc.,administrator for the HealthShares(TM) Exchange-Traded Funds, a series of 20underlying fund portfolios, today announced that effective at the opening oftrading on Thursday November 8, 2007 Given Imaging, Ltd. (Nasdaq: GIVN) willreplace Dade Behring Holdings, Inc. (Nasdaq: DADE), in the HealthShares(TM)Diagnostics Index, and Inverness Medical Innovations (Amex: IMA) will replaceDADE in the HealthShares(TM) Composite Index. Dade Behring is being acquiredby Siemens, Inc.

Companies included in the HealthShares(TM) Diagnostics Index engage inidentification of the existence and extent of a disease, the visuallocalization of a disease by way of imaging, the selection of therapeuticagents appropriate for the disease wherever possible and the monitoring ofdisease progression/therapeutic efficacy.

About HealthShares(TM)

XShares Advisors LLC, a financial services company based in New York, isthe creator of the HealthShares(TM) family of Exchange Traded Funds (ETFs).HealthShares(TM) ETFs are organized into therapeutic 'Verticals' and representspecific areas of the healthcare, life science and biotechnology industries.Each Vertical addresses a distinct sub-segment of healthcare, such as thediagnosis and treatment of specific therapeutic areas (e.g. cardiology,cancer, infectious disease, etc.) and the development of medical devices (e.g.orthopedic repair, cardio devices, etc.). Each ETF tracks an index of 22-25stocks and offers institutional and individual investors a more precisefinancial instrument that leverages the potential of healthcare investingwhile mitigating the risks of single stock picking. For more information,visit the company's website at:

About QED International Associates

QED International, based in New York, is a leading financial industryconsulting firm specializing in quantitative modeling and the design,development and maintenance of indexes and Exchange Traded Funds. For moreinformation, visit the company's website at www.qedinternational.comContact Information For QED International: Ed Matluck, CEO Michael Carty, Senior Advisor Senior Vice President (212) 953-4058

SOURCE QED International Associates Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
APHA Adopts New Policies on Food Safety, Global Cl...
FDA Grants Kiadis Pharma Lead Product ATIR Orphan ...